Research and Development of High-Resolution Inspection Systems and a Common Platform
First written in FY2016. 26 of 32 entries say "Restated". Latest entry: 2026-08-05.
0 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total R&D expenditure for the current fiscal year was ¥256 million. With the generative AI market growing rapidly, semiconductor package substrates are rapidly moving toward chiplet architectures and finer wiring. In response, in July 2025 the Company released the SX7000 series of semiconductor package substrate inspection equipment, compatible with L/S=1.5μm/1.5μm, and the LX7000 repair equipment for correcting short defects on substrates with L/S=5μm/5μm. The Company now offers a product lineup that can help improve yields for next-generation substrates.」
The Company recorded R&D expenditure of ¥256 million and commercialized its development results, from fine-wiring inspection through defect repair, with the release of the SX7000 and LX7000. - 2026-07-02AdvancedGeneral Meetings of Shareholders
「Going forward, we will further accelerate the development of high-precision inspection technology compatible with increasingly fine and dense wiring patterns, while advancing image processing using AI technology and increasing inspection speed.」
The direction of research and development has been specified as including more advanced AI image processing and faster inspection, in addition to higher precision. - FY2026-H1RestatedAnnual report
「R&D expenditure for the current interim accounting period was ¥124 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities, with R&D expenditure reaching ¥124 million for the current interim accounting period. It stated that there had been no material changes in the status of those activities. - FY2025-H1RestatedAnnual report
「R&D expenditure for the current interim accounting period was ¥200 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥200 million and stated that there had been no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「Total R&D expenditure for the current fiscal year was ¥425 million. With the AI market growing rapidly, semiconductor package substrates are rapidly moving toward chiplet architectures and finer wiring. In response, the Company is developing the SX7000 series of package substrate inspection equipment, compatible with L/S=1.5μm/1.5μm, to support further miniaturization. It is also preparing repair equipment for correcting short defects on substrates with L/S=5μm/5μm.」
R&D expenditure reached ¥425 million, with specific development projects including the SX7000 series, repair equipment, faster and AI-enabled RA series equipment, and next-generation exposure equipment. - FY2024-Q3RestatedAnnual report
「R&D expenditure for the third quarter of the current cumulative period was ¥309 million. There were no material changes in the status of the Company's R&D activities during the period.」
R&D expenditure reached ¥309 million for the cumulative third quarter, but the Company stated that there had been no material changes in the status of its R&D activities. - FY2024-Q2RestatedAnnual report
「R&D expenditure for the second quarter of the current cumulative period was ¥209 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities, with R&D expenditure reaching ¥209 million for the cumulative second quarter. It stated that there had been no material changes in the status of those activities. - FY2024-Q1RestatedAnnual report
「R&D expenditure for the first quarter of the current cumulative period was ¥107 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥107 million and stated that there had been no material changes in the status of its R&D activities. - FY2023-Q3RestatedAnnual report
「R&D expenditure for the third quarter of the current cumulative period was ¥214 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities and recorded cumulative R&D expenditure of ¥214 million. It stated that there had been no material changes in the status of its R&D activities. - FY2023-Q2RestatedAnnual report
「R&D expenditure for the second quarter of the current cumulative period was ¥146 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥146 million but stated that there had been no material changes in the status of its R&D activities. - FY2023-Q1RestatedAnnual report
「R&D expenditure for the three months ended the first quarter was ¥81 million. There were no material changes in the status of the company's R&D activities during the three months ended the first quarter.」
The Company continued its R&D activities, with R&D expenditure reaching ¥81 million for the cumulative first quarter. It stated that there had been no material changes in the status of those activities. - FY2022RestatedAnnual report
「Total R&D expenditure for the current fiscal year was ¥227 million. The Company accelerated and enhanced the functionality of the image-processing system at the core of its inspection equipment, while also developing an imaging system using new devices and high-performance lenses.」
The Company continued developing faster, higher-functionality image-processing systems, imaging systems using new devices, high-performance lenses, and next-generation exposure equipment. R&D expenditure reached ¥227 million. - FY2022-Q2RestatedAnnual report
「R&D expenditure for the second quarter of the current cumulative period was ¥112 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities and recorded cumulative R&D expenditure of ¥112 million. It stated that there had been no material changes in the status of those activities. - FY2022-Q1RestatedAnnual report
「R&D expenditure for the first quarter of the current cumulative period was ¥56 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥56 million and stated that there had been no material changes in the status of its R&D activities. - FY2021-Q3RestatedAnnual report
「R&D expenditure for the third quarter of the current consolidated cumulative period was ¥136 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥136 million but stated that there had been no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「R&D expenditure for the second quarter of the current consolidated cumulative period was ¥90 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥90 million and stated that there had been no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「R&D expenditure for the first quarter of the current consolidated cumulative period was ¥40 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities, with R&D expenditure reaching ¥40 million for the cumulative quarter. It stated that there had been no material changes in the status of those activities. - FY2020RestatedAnnual report
「Total R&D expenditure for the current consolidated fiscal year was ¥161 million. The main projects were the development of image-processing systems for roll-to-roll applications and high-speed inline inspection systems for the Company's inspection equipment, the development of an AI-based defect classification system, and the development of a roll-to-roll seamless laser direct imaging exposure machine.」
The Company recorded R&D expenditure of ¥161 million, covering the development of roll-to-roll image processing, high-speed inline inspection, AI-based defect classification, and a new laser direct imaging exposure machine. - FY2020-Q3RestatedAnnual report
「R&D expenditure for the third quarter of the current consolidated cumulative period was ¥121 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities, with R&D expenditure reaching ¥121 million for the cumulative third quarter. It stated that there had been no material changes in the status of those activities. - FY2020-Q2RestatedAnnual report
「R&D expenditure for the second quarter of the current consolidated cumulative period was ¥80 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company recorded R&D expenditure of ¥80 million and explained that there had been no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expenditure for the first quarter of the current consolidated cumulative period was ¥36 million. There were no material changes in the status of the Company's R&D activities during the period.」
The Company continued its R&D activities, recording R&D expenditure of ¥36 million for the cumulative quarter and reporting no material change in the status of those activities. - FY2019RestatedAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥128 million. Major expenditures related to the development of an image-processing system for roll-to-roll applications, a high-speed inline inspection system and an AI-based defect classification system for the Company's inspection equipment.」
The Company continued research and development, focusing on image processing for roll-to-roll applications, high-speed inline inspection and AI-based defect classification. Research and development expenses were ¥128 million. - FY2019-Q3RestatedAnnual report
「Research and development expenses for the first nine months of the current consolidated fiscal year were ¥93 million. There were no significant changes in the status of the Company's research and development activities during the first nine months.」
Research and development continued, with cumulative research and development expenses of ¥93 million. The Company stated that there were no significant changes in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「Research and development expenses for the first six months of the current consolidated fiscal year were ¥63 million. There were no significant changes in the status of the Company's research and development activities during the first six months.」
The Company recorded research and development expenses of ¥63 million and stated that there were no significant changes in the status of its research and development activities. - FY2018RestatedAnnual report
「Total research and development expenses for the current consolidated fiscal year were ¥130 million. Major expenditures related to the development of defect classification software for the Company's inspection equipment, improvements to optical systems, development of image-processing engine software, development of large plotters by its subsidiary First EIE SA, and development of new products by Path Imaging Co., Ltd.」
The Company continued research and development in defect classification software, optical systems, image-processing engines, large plotters and new products from Path Imaging. Annual research and development expenses were ¥130 million. - FY2018-Q3RestatedAnnual report
「Research and development expenses for the first nine months of the current consolidated fiscal year were ¥105 million. There were no significant changes in the status of the Company's research and development activities during the first nine months.」
Research and development continued, with cumulative research and development expenses of ¥105 million and no significant changes in the status of the activities. - FY2018-Q2RestatedAnnual report
「Research and development expenses for the first six months of the current consolidated fiscal year were ¥71 million. There were no significant changes in the status of the Company's research and development activities during the first six months.」
The Company recorded research and development expenses of ¥71 million and stated that there were no significant changes in the status of its research and development activities. - FY2018-Q1RestatedAnnual report
「Research and development expenses for the first quarter of the current consolidated fiscal year were ¥34 million. There were no significant changes in the status of the Company's research and development activities during the first quarter.」
Research and development continued, with research and development expenses of ¥34 million for the first quarter and no significant changes in the status of the activities. - FY2017-Q2RestatedAnnual report
「Research and development expenses for the first six months of the current consolidated fiscal year were ¥55 million. There were no significant changes in the status of the Company's research and development activities during the first six months.」
Research and development continued, with research and development expenses of ¥55 million for the first six months and no significant changes in the status of the activities. - FY2016First statedAnnual report
「In research and development, development of high-resolution inspection systems focused mainly on board AOI and the standardization of base machines progressed almost as planned. The Company is developing the AV500 with a new host computer as a standard product and is systematically operating 3D CAD to improve and develop various lighting systems. It has completed converting most current products to LED lighting.」
The Company identified high-resolution inspection, base-machine standardization, AV500 standardization, 3D CAD, lighting-system improvements and LED conversion as specific research and development initiatives.